Harmony Biosciences Holdings (HRMY)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Long-term debt US$ in thousands 163,016 167,847 171,422 174,996 178,566 182,131 180,487 185,063 189,647 189,725 189,807 189,896 189,984 190,069 195,610
Total assets US$ in thousands 999,200 928,135 858,383 846,985 811,448 777,766 760,183 715,092 673,870 643,464 505,034 464,005 433,443 391,092 359,695
Debt-to-assets ratio 0.16 0.18 0.20 0.21 0.22 0.23 0.24 0.26 0.28 0.29 0.38 0.41 0.44 0.49 0.54

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $163,016K ÷ $999,200K
= 0.16

The debt-to-assets ratio of Harmony Biosciences Holdings has been showing a consistent decreasing trend over the analyzed period, indicating a healthier financial position in terms of asset coverage by debt. The ratio decreased from 0.54 as of June 30, 2021, to 0.16 as of December 31, 2024. This suggests that the company has been gradually reducing its debt relative to its total assets, which can be a positive sign for the company's financial stability and solvency. A decreasing debt-to-assets ratio may signify efficient debt management, improved operational performance, and potentially lower financial risk for the company.